# Recombinant Human Prolactin for Lactation Induction

> **NCT00181649** · PHASE2 · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Lactation

## Interventions

- **DRUG:** Recombinant human prolactin

## Key facts

- **NCT ID:** NCT00181649
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-09
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Not able to recruit any subjects.
- **Last updated:** 2013-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00181649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00181649, "Recombinant Human Prolactin for Lactation Induction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00181649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*